These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 28382157)

  • 1. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
    Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
    Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors targeting the influenza virus hemagglutinin.
    Li F; Ma C; Wang J
    Curr Med Chem; 2015; 22(11):1361-82. PubMed ID: 25723505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies of development of antiviral agents directed against influenza virus replication.
    Hsieh HP; Hsu JT
    Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.
    Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D
    J Prev Med Hyg; 2014 Dec; 55(4):109-29. PubMed ID: 26137785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential targets and their relevant inhibitors in anti-influenza fields.
    Gong J; Fang H; Li M; Liu Y; Yang K; Liu Y; Xu W
    Curr Med Chem; 2009; 16(28):3716-39. PubMed ID: 19747144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-influenza virus agent].
    Nakamura S; Kohno S
    Nihon Rinsho; 2012 Apr; 70(4):568-73. PubMed ID: 22568136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging antiviral therapies and drugs for the treatment of influenza.
    Wang J; Sun Y; Liu S
    Expert Opin Emerg Drugs; 2022 Dec; 27(4):389-403. PubMed ID: 36396398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fight Against H1N1 Influenza A Virus: Recent Insights Towards the Development of Druggable Compounds.
    Tonelli M; Cichero E
    Curr Med Chem; 2016; 23(18):1802-17. PubMed ID: 26861005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the Mechanisms of Active Compounds in Traditional Chinese Medicine for the Treatment of Influenza Virus by Virtual Screening.
    Ai H; Wu X; Qi M; Zhang L; Hu H; Zhao Q; Zhao J; Liu H
    Interdiscip Sci; 2018 Jun; 10(2):320-328. PubMed ID: 29500549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The substances active against influenza virus. Possibilities and prospects of application].
    Kwiatek M; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
    Ludwig S
    Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.
    Zhang Q; Liang T; Nandakumar KS; Liu S
    Expert Opin Pharmacother; 2021 Apr; 22(6):715-728. PubMed ID: 33327812
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigational hemagglutinin-targeted influenza virus inhibitors.
    Zeng LY; Yang J; Liu S
    Expert Opin Investig Drugs; 2017 Jan; 26(1):63-73. PubMed ID: 27918208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds.
    Lepri S; Nannetti G; Muratore G; Cruciani G; Ruzziconi R; Mercorelli B; Palù G; Loregian A; Goracci L
    J Med Chem; 2014 May; 57(10):4337-50. PubMed ID: 24785979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.